Nerve Pain Treatment: Conventional and Regenerative Options

Nerve pain, also called neuropathic pain or neuralgia, is treated with first-line medications such as gabapentin, pregabalin and duloxetine, and increasingly with regenerative options such as platelet-rich plasma (PRP), low-level laser therapy (LLLT), neurofeedback and ketamine infusions when conventional drugs fall short. An estimated 7% to 10% of the general population experiences neuropathic pain, according to a systematic review by van Hecke et al. (2014).

Nerve pain is unlike any other type of pain. It does not come from a bruise, a torn muscle, or an inflamed joint. Instead, it originates from damage or dysfunction within the nervous system itself. People describe it as burning, electric, shooting, stabbing, or tingling. It can wake you from sleep, make clothing unbearable against your skin, and resist the painkillers that work for other types of pain.

Nerve pain can result from diabetes, shingles, surgery, chemotherapy, spinal conditions, autoimmune disease, multiple sclerosis, or physical injury. Whatever the cause, it tends to be persistent and difficult to manage. Standard anti-inflammatory drugs and opioids are largely ineffective for nerve pain, which is why specific neuropathic pain treatments have been developed.

Working with a healthcare team that understands both conventional and regenerative options, including neurologists, physiatrists and pain management specialists, improves the odds of finding a combination that provides meaningful relief.

Understanding How Nerve Pain Works

To understand why nerve pain is different, it helps to know a little about how it develops. Normally, nerves transmit signals from your body to your brain in an orderly fashion. You touch something hot, the nerve fires, and you pull your hand away. The system works efficiently.

When nerves are damaged, this signaling goes wrong in several ways. Damaged nerve fibers may fire spontaneously without any stimulus. They may amplify normal signals, turning a light touch into searing pain, a phenomenon called allodynia, or an increased response to a normally painful stimulus, called hyperalgesia. The central nervous system may become sensitized, meaning the brain and spinal cord start amplifying pain signals even when the peripheral input is mild, according to Costigan, Scholz and Woolf (2009).

Clinicians broadly classify neuropathic pain as peripheral, arising from damage to nerves outside the brain and spinal cord, or central, arising from damage within the central nervous system itself, as seen in multiple sclerosis or after a stroke. This distinction, together with a physical exam and sometimes nerve conduction testing, helps guide which treatment pathway is most appropriate. Readers researching nerve pain tied to a specific neurological condition can review the multiple sclerosis condition page or the national multiple sclerosis treatment clinic directory for context on that cause specifically.

This is why nerve pain responds to different treatments than inflammation-based pain. Effective nerve pain treatments work by calming overactive nerve signaling, blocking specific pain pathways, or helping damaged nerves repair and regenerate.

Types of Nerve Pain

Nerve pain takes different forms depending on its cause and location.

Peripheral neuropathy is the most common type, affecting the nerves in the hands and feet. Diabetic neuropathy accounts for a large proportion of cases, but it can also result from vitamin deficiencies, especially B12, alcohol use, chemotherapy, and autoimmune conditions, according to a position statement from the American Diabetes Association (Pop-Busui et al., 2017).

Postherpetic neuralgia (PHN) occurs after a shingles outbreak and can persist for months or years after the rash has healed. The varicella-zoster virus damages sensory nerves, causing burning pain in the affected dermatome.

Trigeminal neuralgia produces sudden, severe, shock-like pain in the face. It is caused by compression or irritation of the trigeminal nerve and is considered one of the most intense pain conditions in medicine.

Radiculopathy results from nerve root compression, typically in the spine. Sciatica is the most well-known example, where compression of the lumbar nerve roots causes pain radiating down the leg. Readers dealing specifically with sciatic nerve pain may find the sciatica treatment guide useful alongside this overview.

Complex regional pain syndrome (CRPS) is a chronic condition usually affecting a limb after injury or surgery. It involves persistent, disproportionate pain along with changes in skin color, temperature, and swelling.

Small fiber neuropathy affects the thin sensory nerve fibers responsible for pain and temperature sensation, often producing burning feet and hands even when standard nerve conduction studies, which primarily evaluate larger fibers, come back normal. The small fiber neuropathy guide covers how this subtype is diagnosed and distinguished from other neuropathies.

These nerve-specific conditions often overlap with broader chronic pain syndromes, which is why many patients benefit from evaluating both the nerve-specific cause and overall chronic pain management strategy together, rather than treating nerve pain in isolation.

Conventional Pharmaceutical Treatments

Several medication classes have established evidence for treating neuropathic pain. These are typically first-line options prescribed by primary care physicians, neurologists, and pain management specialists before more specialized procedures are considered.

Gabapentin and Pregabalin

Gabapentinoids are among the most commonly prescribed medications for nerve pain. They work by binding to calcium channels on nerve cells, reducing the release of excitatory neurotransmitters and calming overactive nerve signaling, according to a Cochrane review by Wiffen et al. (2017).

Gabapentin (Neurontin) has been shown to reduce pain and improve sleep in patients with postherpetic neuralgia and diabetic neuropathy. A Cochrane review found that gabapentin provided at least 50% pain reduction in about 30% to 40% of patients, compared to 10% to 20% with placebo. Typical doses range from 900 to 3,600 mg per day, divided into three doses.

Pregabalin (Lyrica) has a similar mechanism but more predictable absorption. It is FDA-approved for diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain, and the fibromyalgia condition page discusses this overlap in more depth. Effective doses typically range from 150 to 600 mg per day, according to a Cochrane review by Derry et al. (2019).

Common side effects of both include dizziness, drowsiness, and weight gain. Starting at a low dose and increasing gradually helps minimize these effects.

Duloxetine and Other SNRIs

Duloxetine (Cymbalta) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain. It works by increasing levels of serotonin and norepinephrine in the descending pain inhibitory pathways, essentially turning up the brain’s natural pain-suppressing system, according to a Cochrane review by Lunn, Hughes and Wiffen (2014).

A meta-analysis found that duloxetine at 60 to 120 mg daily provided clinically meaningful pain relief in about 40% of patients with diabetic neuropathy, compared to 27% with placebo. Venlafaxine, another SNRI, has also shown effectiveness for neuropathic pain, though it is used off-label for this purpose.

Side effects include nausea, dry mouth, constipation, and fatigue. Duloxetine should not be stopped abruptly due to withdrawal effects.

Tricyclic Antidepressants

Older tricyclic antidepressants (TCAs) like amitriptyline and nortriptyline remain effective options for neuropathic pain, particularly when prescribed at doses lower than those used for depression. A systematic review by Moore, Derry, Aldington, Cole and Wiffen (2015) found amitriptyline effective for multiple neuropathic pain conditions.

TCAs work by inhibiting reuptake of both serotonin and norepinephrine, plus they block sodium channels, which may provide additional pain-reducing effects. Typical pain doses range from 25 to 75 mg at bedtime. Their sedating properties can be beneficial for patients whose nerve pain disrupts sleep.

However, TCAs carry more side effects than newer medications, including dry mouth, constipation, urinary retention, and cardiac conduction changes. They require caution in elderly patients and those with heart disease.

Topical Treatments

For localized nerve pain, topical options can provide relief with fewer systemic side effects.

Lidocaine patches (5%) are FDA-approved for postherpetic neuralgia and deliver a local anesthetic directly to the painful area. They are particularly useful when pain is confined to a specific region, according to a Cochrane overview by Derry, Wiffen, Kalso et al. (2017).

Capsaicin cream (0.075%) and high-concentration capsaicin patches (8%) work by depleting substance P from sensory nerve endings. The high-concentration patch, applied by a healthcare provider, can provide pain relief lasting up to 3 months from a single application.

Comparing First-Line Medications

The table below summarizes the medication classes already described, using the dosing and approval information stated above, as a quick reference when discussing options with a prescriber.

Interventional Procedures for Nerve Pain

When medications and topical treatments do not provide enough relief, pain management physicians and anesthesiologists offer interventional procedures aimed at specific nerve pathways rather than systemic drug effects.

Nerve Blocks

A nerve block delivers a local anesthetic, sometimes combined with a steroid, directly around the affected nerve or nerve root. Diagnostic nerve blocks help confirm which nerve is generating pain, while therapeutic blocks aim to interrupt pain signaling for days to months. They are commonly used for radiculopathy, occipital neuralgia, and some cases of CRPS.

Radiofrequency Ablation

Radiofrequency ablation uses heat generated by radio waves to disrupt the function of a targeted sensory nerve, reducing its ability to transmit pain signals. The effect is typically temporary, since the ablated nerve segment tends to regenerate over time, which means the procedure may need to be repeated.

Spinal Cord Stimulation

Spinal cord stimulation involves surgically implanting a small device that delivers mild electrical pulses to the spinal cord, interrupting pain signals before they reach the brain. It is most often considered for CRPS and persistent radiculopathy after spine surgery that has not responded to other treatments. Patients typically undergo a temporary trial period before deciding, with the patient’s physician, whether to proceed with a permanent device.

These procedures sit between conventional medication and the regenerative approaches described below. A pain management specialist can help determine whether a trial of one of these interventions is appropriate before moving on to less established options.

Regenerative and Integrative Approaches

Alongside conventional treatments, several regenerative and integrative approaches show promise for nerve pain, some with strong evidence and others still emerging. Readers who want to compare providers offering any of these approaches can browse regenerated.com’s clinic listings, where ranking order is not paid placement, Featured placements are labeled and capped, Verified status reflects credential checks rather than advertising spend, and browsing the directory itself is free for patients.

PRP for Nerve Pain

Platelet-rich plasma (PRP) therapy has shown intriguing results for certain types of nerve pain. The growth factors in PRP, including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), may support nerve repair and reduce neuroinflammation.

Research is most advanced for PRP in nerve entrapment syndromes. A randomized controlled trial by Malahias, Johnson, Babis and Nikolaou (2015) comparing PRP injection to corticosteroid injection for carpal tunnel syndrome found that PRP provided superior long-term outcomes, with patients maintaining improvement at 6 months while the corticosteroid group’s benefits had faded.

Early research also suggests potential benefits of PRP for peripheral neuropathy. A pilot study by Anjayani et al. (2014) found that perineural PRP injection improved symptoms and nerve conduction studies in patients with diabetic neuropathy. However, larger trials are needed before PRP can be considered a standard treatment for neuropathy, and evidence for this specific use remains thin.

PRP injections for nerve pain are typically performed under ultrasound guidance to ensure accurate placement near the affected nerve. A series of 2 to 4 injections spaced 2 to 4 weeks apart is common. Readers can explore the PRP treatment guide for how the procedure is prepared and administered, and the national PRP clinic directory to compare providers in a given metro.

Stem Cell Therapy for Nerve Regeneration

Stem cell therapy for nerve damage and neuropathic pain is an active area of research. Mesenchymal stem cells (MSCs) have been shown to secrete neurotrophic factors that support nerve survival and regeneration, modulate inflammation, and potentially remyelinate damaged nerves, according to a review by Liau et al. (2020).

Animal studies have demonstrated meaningful nerve regeneration with MSC therapy in models of peripheral nerve injury and diabetic neuropathy. Human clinical trials are underway but still in early phases.

It is important to be cautious about clinics offering stem cell therapy for nerve pain outside of clinical trials. The evidence is not yet sufficient to establish efficacy, optimal cell source, dosing, or delivery method for most neuropathic pain conditions. If you are interested in stem cell therapy, seek out centers participating in registered clinical trials, and review the stem cell therapy treatment guide or the national stem cell therapy clinic directory as a starting point for questions to ask a prospective provider.

Low-Level Laser Therapy (LLLT)

Low-level laser therapy, also called photobiomodulation or cold laser therapy, uses specific wavelengths of light to stimulate cellular energy production and reduce inflammation. The mechanism involves absorption of photons by cytochrome c oxidase in mitochondria, which enhances ATP production and activates various cellular signaling pathways, according to Bjordal, Johnson, Iversen, Aimbire and Lopes-Martins (2006).

For nerve pain specifically, a systematic review and meta-analysis found that LLLT produced significant reductions in pain intensity for patients with diabetic peripheral neuropathy, carpal tunnel syndrome, and postherpetic neuralgia. The treatment is non-invasive, generally well tolerated, and can be used alongside other therapies.

Typical protocols involve 2 to 3 sessions per week for 4 to 8 weeks. Results tend to be cumulative, with the full benefit appearing after the complete treatment course. Home devices are available, though their power output is generally lower than clinical units. The laser therapy (LLLT) treatment guide and the national laser therapy clinic directory cover what a typical course looks like in more detail.

Neurofeedback

Neurofeedback is a form of biofeedback that trains patients to modify their own brain activity. Sensors placed on the scalp measure brain waves (EEG), and the patient receives real-time feedback, usually through a visual or auditory display, that rewards specific patterns of brain activity associated with reduced pain processing.

The rationale is that chronic pain alters brain activity patterns, and neurofeedback can help normalize these patterns. A systematic review by Roy, de la Vega, Jensen and Miró (2020) found that neurofeedback training showed promising results for chronic pain conditions, including neuropathic pain, with reductions in pain intensity and improvements in quality of life.

Neurofeedback typically requires 20 to 40 sessions for full effect, making it a significant time commitment. It is most appropriate for chronic, treatment-resistant nerve pain and works best as part of a multimodal treatment approach rather than a standalone therapy. The neurofeedback therapy treatment guide and the national neurofeedback therapy clinic directory list what a typical evaluation and session series involve.

Ketamine Therapy

Ketamine, an NMDA receptor antagonist, has gained attention as a treatment for severe, treatment-resistant neuropathic pain. NMDA receptors play a central role in central sensitization, the process by which the spinal cord and brain amplify pain signals. By blocking these receptors, ketamine can interrupt the cycle of central sensitization.

Intravenous ketamine infusions have shown effectiveness in multiple neuropathic pain conditions, including CRPS, postherpetic neuralgia, and central neuropathic pain. A systematic review by Orhurhu, Orhurhu, Bhatia and Cohen (2019) found that IV ketamine provided significant short-term pain relief in patients with refractory neuropathic pain.

Newer delivery methods include intranasal, oral, and topical ketamine formulations, though IV infusion remains the most studied. Treatment typically involves a series of infusions over several days to weeks, with some patients experiencing lasting relief and others requiring periodic maintenance infusions. The ketamine infusion therapy explainer walks through what a typical infusion appointment involves.

Side effects can include dissociation, dizziness, nausea, and elevated blood pressure during infusion. Ketamine should only be administered by trained providers in a monitored setting. It is typically reserved for patients who have not responded adequately to first-line treatments. The ketamine therapy treatment guide and the national ketamine therapy clinic directory are useful starting points for comparing monitored infusion providers.

Regenerative and Integrative Options at a Glance

Most of these regenerative and integrative options are cash pay and several are used off label for neuropathic pain, so it is worth asking any prospective provider directly how they define success for your specific condition before starting a course of treatment.

Lifestyle Approaches That Support Nerve Health

Alongside medical treatments, several lifestyle factors can meaningfully influence nerve pain.

Exercise

Regular physical activity has been shown to reduce neuropathic pain through multiple mechanisms, including improved blood flow to nerves, release of endogenous opioids, and modulation of neuroinflammation. A systematic review by Kluding, Pasnoor, Singh et al. (2012) found that exercise interventions improved pain, physical function, and nerve conduction measures in patients with diabetic peripheral neuropathy.

Both aerobic exercise and resistance training appear beneficial. Start gently and progress gradually, especially if balance is affected by neuropathy. Swimming and cycling may be easier than walking for people with foot pain.

Blood Sugar Management

For diabetic neuropathy, optimizing blood glucose control is the single most important intervention. Tight glycemic control can slow the progression of neuropathy and, in some cases, lead to partial reversal of nerve damage, particularly in early stages, according to the American Diabetes Association position statement by Pop-Busui et al. (2017).

Nutrient Support

Several nutrients are important for nerve health:

• B vitamins (especially B12, B6, and folate) are essential for nerve function and myelin maintenance. B12 deficiency itself can cause neuropathy.
• Alpha-lipoic acid at 600 mg daily has been shown to improve symptoms of diabetic neuropathy in several clinical trials.
• Acetyl-L-carnitine may support nerve regeneration and has shown benefits in some neuropathy studies.
• Omega-3 fatty acids have anti-inflammatory properties that may help reduce neuroinflammation.

Stress Management

Chronic stress amplifies pain perception through the hypothalamic-pituitary-adrenal axis. Mindfulness-based stress reduction (MBSR) has been shown to reduce pain intensity and improve coping in chronic pain conditions. Practices like meditation, deep breathing, and yoga can be valuable additions to a nerve pain management plan.

Building a Treatment Plan

Effective nerve pain management usually requires a combination of approaches, treating nerve pain from multiple angles rather than relying on a single medication or procedure. A reasonable progression looks like this:

1. Identify and treat the underlying cause (blood sugar control for diabetes, B12 supplementation for deficiency, treating the source of nerve compression)
2. First-line medications (gabapentinoid or SNRI, or both together for refractory pain)
3. Topical treatments for localized pain (lidocaine, capsaicin)
4. Lifestyle optimization (exercise, nutrition, stress management)
5. Interventional procedures (nerve blocks, radiofrequency ablation, or spinal cord stimulation for structurally defined pain)
6. Regenerative or integrative additions (LLLT, PRP for entrapment syndromes, neurofeedback for chronic pain)
7. Ketamine or other advanced options for treatment-resistant cases

Patients who want to reduce reliance on opioids or add non-drug strategies to this progression may find the chronic pain management without opioids overview and the broader chronic pain treatment guide helpful companions to this plan.

When to See a Specialist

Seek medical evaluation promptly if you experience:

• Sudden onset of nerve pain without obvious cause
• Progressive weakness in the hands or feet
• Loss of bladder or bowel control alongside back pain (this is a medical emergency)
• Nerve pain following a new medication
• Symptoms spreading to new areas of the body
• Pain that is not adequately controlled despite treatment

A neurologist can perform nerve conduction studies and electromyography to characterize the type and extent of nerve damage, which helps guide treatment decisions. Pain management specialists can offer interventional procedures and multimodal treatment plans, and a physiatrist can help coordinate rehabilitation alongside either specialty.

Frequently asked questions

What is the best medication for nerve pain?

There is no single best medication for every patient. Gabapentin, pregabalin, duloxetine, and tricyclic antidepressants such as amitriptyline are the main first-line options, and each has a different side effect profile. Many prescribers start with a gabapentinoid or duloxetine and adjust based on response, tolerability, and other conditions such as fibromyalgia or depression that the medication might also address.

Does nerve pain ever go away, or is it permanent?

It depends on the cause. Nerve pain from a reversible trigger, such as a vitamin B12 deficiency or a temporary nerve compression, often improves once the underlying problem is corrected. Nerve pain from longstanding diabetes, chemotherapy-induced nerve damage, or postherpetic neuralgia is more likely to be chronic, though combinations of medication, lifestyle change, and regenerative or interventional options can still meaningfully reduce its intensity.

What is the strongest non-drug treatment for nerve pain?

Evidence varies by condition rather than pointing to one universal answer. Low-level laser therapy has supported evidence across diabetic peripheral neuropathy, carpal tunnel syndrome, and postherpetic neuralgia. Exercise and tight blood sugar control show the strongest support specifically for diabetic neuropathy. The right choice depends on the type of nerve pain and what has already been tried.

Can nerve pain be treated with regenerative medicine?

Some regenerative options have real, if still developing, support. PRP has the most direct evidence for nerve entrapment syndromes like carpal tunnel syndrome. Stem cell therapy for neuropathic pain remains largely investigational, with most support coming from animal studies rather than large human trials. Evidence is thinner for broader nerve damage, so expectations should match the current research rather than marketing claims.

How long does it take for nerve pain treatment to start working?

Timelines differ by treatment. Gabapentinoids and SNRIs are usually titrated over several weeks to find an effective, tolerable dose. LLLT protocols run 4 to 8 weeks with cumulative benefit. Neurofeedback typically requires 20 to 40 sessions before full effect. Ketamine infusions can produce short-term relief within days, though the duration of that relief varies between patients.

What type of doctor treats nerve pain?

Neurologists diagnose and manage nerve pain using nerve conduction studies and electromyography, pain management specialists and anesthesiologists offer interventional procedures such as nerve blocks and spinal cord stimulation, and physiatrists coordinate broader rehabilitation. Primary care physicians often manage first-line medications and make referrals when pain is not adequately controlled or when red-flag symptoms appear.

The Bottom Line

Nerve pain is one of the more challenging types of chronic pain to manage, affecting an estimated 7% to 10% of the general population, but the treatment options continue to expand. Conventional medications like gabapentinoids, SNRIs, and tricyclic antidepressants remain the foundation of treatment, with interventional procedures such as nerve blocks and spinal cord stimulation available for structurally defined pain. Regenerative approaches, including PRP, LLLT, and neurofeedback, offer additional tools that work alongside conventional care, with PRP's evidence strongest for nerve entrapment syndromes. Ketamine provides an option for severe, refractory cases that have not responded to first-line treatment.

The key is to address nerve pain from multiple angles: treat the underlying cause, use medications that target neuropathic pain pathways, optimize lifestyle factors that support nerve health, and consider interventional or regenerative options that may support healing rather than just managing symptoms. Working with a knowledgeable healthcare team that understands both conventional and integrative options, and comparing providers through resources like the national PRP, laser therapy, neurofeedback, and ketamine therapy clinic directories, gives you the best chance of meaningful relief. Inclusion in any of these directories reflects that a clinic completed the listing process, not an endorsement of outcomes.

Sources

1. van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654-662. doi:10.1016/j.pain.2013.11.013
2. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32:1-32. doi:10.1146/annurev.neuro.051508.135531
3. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154. doi:10.2337/dc16-2042
4. Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6(6):CD007938. doi:10.1002/14651858.CD007938.pub4
5. Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;1(1):CD007076. doi:10.1002/14651858.CD007076.pub3
6. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;(1):CD007115. doi:10.1002/14651858.CD007115.pub3
7. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;(7):CD008242. doi:10.1002/14651858.CD008242.pub3
8. Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;5(5):CD008609. doi:10.1002/14651858.CD008609.pub2
9. Malahias MA, Johnson EO, Babis GC, Nikolaou VS. Single injection of platelet-rich plasma as a novel treatment of carpal tunnel syndrome. Neural Regen Res. 2015;10(11):1856-1859. doi:10.4103/1673-5374.165322
10. Anjayani S, Wirohadidjojo YW, Adam AM, Suwandi D, Seweng A, Amiruddin MD. Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. Int J Dermatol. 2014;53(1):109-113. doi:10.1111/ijd.12162
11. Liau LL, Looi QH, Chia WC, Subramaniam T, Ng MH, Law JX. Treatment of spinal cord injury with mesenchymal stem cells. Cell Biosci. 2020;10:36. doi:10.1186/s13578-020-00396-1
12. Bjordal JM, Johnson MI, Iversen V, Aimbire F, Lopes-Martins RA. Low-level laser therapy in acute pain: a systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. Photomed Laser Surg. 2006;24(2):158-168. doi:10.1089/pho.2006.24.158
13. Roy R, de la Vega R, Jensen MP, Miró J. Neurofeedback for pain management: a systematic review. Front Neurosci. 2020;14:671. doi:10.3389/fnins.2020.00671
14. Orhurhu V, Orhurhu MS, Bhatia A, Cohen SP. Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2019;129(1):241-254. doi:10.1213/ANE.0000000000004185
15. Kluding PM, Pasnoor M, Singh R, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012;26(5):424-429. doi:10.1016/j.jdiacomp.2012.05.007